ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Ying Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6348-6937; OpenAlex author ID A5100347280. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. Co-author DOI 10.1016/j.ijbiomac.2024.134517 ↗
Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. Last author DOI 10.1016/j.ejpb.2023.09.014 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Epiphane K. Silli · 2 shared papers, 2023–2024 · strength 0.37
- Paper Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. DOI 10.1016/j.ejpb.2023.09.014 ↗
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517 ↗
Zhenjiang Zheng · 1 shared paper, 2024 · strength 0.18
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517 ↗
Chunlu Tan · 1 shared paper, 2024 · strength 0.18
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517 ↗
Yonghua Chen · 1 shared paper, 2024 · strength 0.18
- Paper Growth inhibition of pancreatic cancer by targeted delivery of gemcitabine via fucoidan-coated pH-sensitive liposomes. DOI 10.1016/j.ijbiomac.2024.134517 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.